Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy. - Wikidata - wikimedia - TriplyDB

Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy.

Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy.

http://www.wikidata.org/entity/Q37074084

about

MicroRNAs in Valvular Heart Diseases: Potential Role as Markers and Actors of Valvular and Cardiac Remodeling Epigenetics in heart failure phenotypes Facts and updates about cardiovascular non-coding RNAs in heart failure Micro-RNA-21 (biomarker) and global longitudinal strain (functional marker) in detection of myocardial fibrotic burden in severe aortic valve stenosis: a pilot study Non-coding RNAs in cardiac hypertrophy.Disruption of Ah Receptor Signaling during Mouse Development Leads to Abnormal Cardiac Structure and Function in the Adult.Circulating microRNA Profiling Needs Further Refinement Before Clinical Use in Patients With Aortic Stenosis.Resveratrol Ameliorates Cardiac Hypertrophy by Down-regulation of miR-155 Through Activation of Breast Cancer Type 1 Susceptibility Protein.Inhibition of miR-155 Protects Against LPS-induced Cardiac Dysfunction and Apoptosis in Mice.miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204.Mitochondrial long noncoding RNAs as blood based biomarkers for cardiac remodeling in patients with hypertrophic cardiomyopathy.Genetics and Genomics of Single-Gene Cardiovascular Diseases: Common Hereditary Cardiomyopathies as Prototypes of Single-Gene Disorders.Experimental, Systems, and Computational Approaches to Understanding the MicroRNA-Mediated Reparative Potential of Cardiac Progenitor Cell-Derived Exosomes From Pediatric Patients.More than Just a Simple Cardiac Envelope; Cellular Contributions of the Epicardium.Identification of novel microRNAs in the sheep heart and their regulation in heart failure.Epigenome alterations in aortic valve stenosis and its related left ventricular hypertrophy.Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis.microRNA-206 correlates with left ventricular function after transcatheter aortic valve implantation.microRNA-132: a new biomarker of heart failure at last?[Non-coding RNA : Innovative regulators with therapeutic perspective].MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM.MicroRNAs distribution in different phenotypes of Aortic Stenosis.

P2860

Q26740102-2FC408EF-8D5B-46B7-A1CC-3DC6B76FFE3D Q26747565-A95C2FB7-6E61-465F-920D-1E8DBE1ED654 Q28072307-780ABC4C-16FD-4EE0-938D-2A5A8CECE86F Q30375735-4962199A-141B-4883-BCEC-DF77D8B7D452 Q33800147-0CF52238-4BA2-4B48-8667-59E9635250C1 Q35837597-5F50B162-C5A8-456F-9FE2-854F59C7D76B Q36141660-93C3E1D5-92AB-44F0-9974-56EDD3794D02 Q36831838-1888CF1B-2E8B-4A63-90F1-C27858B3799D Q37393972-6F308A3A-CB7B-4017-97B2-384D5B67F387 Q38669417-80796640-A34A-40E8-A5C4-1A303975A0E8 Q38841302-9919CE08-A9AC-4717-99A5-CC41515E7079 Q39050554-299762B9-288E-42A4-BAFE-E3B860D067FA Q39166735-1BCCB781-59A0-4779-B71C-8DC88A83F2C3 Q39308903-35F8410E-FE81-4D43-8DDD-14A004E54ED9 Q41418643-2BC15671-96D1-4254-8AD7-869C525043E6 Q42281204-14B7C111-46F0-40DA-83B3-AB82CD00B61E Q42515078-ECE8278F-65F9-4EAA-9A5C-8C7FB62E7958 Q47843525-476A49E2-509E-4647-BFA0-7717E2313199 Q50066978-F6B86E57-2A90-40CB-9863-D407DA475C43 Q50100388-73CACA79-B8D7-46AD-BE95-7CD95908551C Q52752598-14746908-1000-40EE-BF75-16A731B57E71 Q55220551-5E368938-E501-4A48-8520-F9EE537D2479 Q55475420-754C8FD2-669C-471E-B7CF-2F4BF1E4C490

P2860

Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy.

http://www.wikidata.org/entity/Q37074084

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 June 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy.

@en

Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy.

@nl

type

label

Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy.

@en

Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy.

@nl

prefLabel

Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy.

@en

Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy.

@nl

P1433

Q37074084-1586B698-EC59-4D2E-84D9-910578FD67BD

P1476

Q37074084-51FAEEAF-D023-4ECF-8F45-FC80142AF2DA

P2093

Q37074084-2CC88F74-519C-46B8-9579-F53DF2311A2E

Q37074084-3B85D25A-8C2E-4567-ACE8-A913BCA1AC89

Q37074084-3F5C83AB-FE6C-442F-8FFD-7BA720237645

Q37074084-4670987A-C6FD-4FE9-A60E-2C2536EE0E69

Q37074084-583400D2-70AB-46B1-A8A7-278E6FB39E83

Q37074084-7D1E6BE1-E267-4BAE-A2CC-56DD43610051

Q37074084-A8AB35B1-5A88-426E-8791-9E9349B04A8D

Q37074084-C310494E-DB74-4882-A16E-1EDDFD913986

Q37074084-DFA54221-8835-4700-AE27-030B9E10A6F4

Q37074084-F58371C7-F4D5-4F6B-ABB9-D0023D8B83AD

P2860

Q37074084-1EA621E8-67BF-4D0B-B017-0C62C49CBF17

Q37074084-28C9BC1D-F2D9-421A-AA4A-6E6F95A7C29D

Q37074084-344A8656-FE4B-4188-9CC3-E26CBA8B37EF

Q37074084-3937B66B-5A83-4397-BD0E-C888231F6F06

Q37074084-48BD9D4F-02A4-43C5-8EC6-8754BD69148D

Q37074084-74700901-96C9-45E3-936E-A52C2DE63E63

Q37074084-7D553CF4-FD44-4FBE-A08E-63A8A69CB73A

Q37074084-8E83398D-A653-4FFB-8B71-3C050776188F

Q37074084-A6D3D4F7-1B94-45AE-8AC0-F4BC96344602

Q37074084-B8CA7E19-E795-4E9A-BEE8-A8FA7C7A1DCB

P304

Q37074084-A0A811D8-ADD3-439C-BF7F-2D360AF0936D

P31

Q37074084-28A8C56A-287E-427E-9FAD-DF766E53315D

P356

Q37074084-45B0DE8F-FF91-4A63-A257-CB7B91B59DE9

P478

Q37074084-8BF047FB-E999-4F50-B28C-26989DA2AC26

P50

Q37074084-2180C5B4-63F4-4BB8-8E3B-77872DC66DBD

Q37074084-333A4EE0-8EDE-4550-8BC6-8728F55C5EC8

P577

Q37074084-FF229185-64FD-4905-A299-7BFF872ADBA2

P698

Q37074084-96294F25-11AF-4C7E-AF4D-12260ED533C7

P921

Q37074084-517C9106-070E-47CF-9DA3-5E6618E580E3

P932

Q37074084-8F74FE5C-E4A3-431F-BB11-1F6722E89E65

P356

J.IJCARD.2015.05.185

P1433

International Journal of Cardiology

P1476

Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy

@en

P2093

Anselm A Derda

http://www.w3.org/2001/XMLSchema#string

Britta Keyser

http://www.w3.org/2001/XMLSchema#string

Joerg Heineke

http://www.w3.org/2001/XMLSchema#string

Johan M Lorenzen

http://www.w3.org/2001/XMLSchema#string

Johann Bauersachs

http://www.w3.org/2001/XMLSchema#string

Julian D Widder

http://www.w3.org/2001/XMLSchema#string

P Christian Schulze

http://www.w3.org/2001/XMLSchema#string

Raymond C Givens

http://www.w3.org/2001/XMLSchema#string

Sabrina Thum

http://www.w3.org/2001/XMLSchema#string

Thomas Thum

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy

SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway

MicroRNA-133 controls cardiac hypertrophy

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

Regulation of the MIR155 host gene in physiological and pathological processes.

MiR-451 is decreased in hypertrophic cardiomyopathy and regulates autophagy by targeting TSC1.

MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles.

Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma

Myocardial fibrosis induced by exposure to subclinical lipopolysaccharide is associated with decreased miR-29c and enhanced NOX2 expression in mice

P304

115-122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJCARD.2015.05.185

http://www.w3.org/2001/XMLSchema#string

P478

196

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26086795

http://www.w3.org/2001/XMLSchema#string

P921

P932

4936391

http://www.w3.org/2001/XMLSchema#string